Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Belongia, Edward A. ; Kieke, Burney ; Lynfield, Ruth ; Davis, Jeffrey P. ; Besser, Richard E.
• Description:
  Media reports suggested increased public demand for anthrax prophylaxis after the intentional anthrax cases in 2001, but the magnitude of anthrax-related prescribing in unaffected regions was not assessed. We surveyed a random sample of 400 primary care clinicians in Minnesota and Wisconsin to assess requests for and provision of anthrax-related antimicrobial agents. The survey was returned by 239 (60%) of clinicians, including 210 in outpatient practice. Fifty-eight (28%) of those in outpatient practice received requests for anthrax-related antimicrobial agents, and 9 (4%) dispensed them. Outpatient fluoroquinolone use in both states was also analyzed with regression models to compare predicted and actual use in October and November 2001. Fluoroquinolone use as a proportion of total antimicrobial use was not elevated, and anthrax concerns accounted for an estimated 0.3% of all fluoroquinolone prescriptions. Most physicians in Minnesota and Wisconsin managed anthrax-related requests without dispensing antimicrobial agents.
• Subjects:
  Anthrax Anti-Bacterial Agents Antibiotic Prophylaxis Bacillus Anthracis Bioterrorism Fluoroquinolones Health Care Surveys Minnesota Outpatients Patient Acceptance Of Health Care Physician'S Practice Patterns Primary Health Care Research

  More +
• Source:
  Emerg Infect Dis. 11(1):42-47.
• Document Type:
  Journal Article
• Funding:
  U50/CCU 515878/CC/ODCDC CDC HHS/United States
• Place as Subject:
  Wisconsin
• Location:
  North America
• Volume:
  11
• Issue:
  1
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:709764cf254ab0945239c378da310137518c13a4e67ad4e56ac16a4d766b5e8b
• Download URL:
  https://stacks.cdc.gov/view/cdc/7795/cdc_7795_DS1.pdf
• File Type:
  [PDF - 109.54 KB ]